B. Hobo

Medicine & Life Sciences

1. N-palmitoylsphingosine 100%
2. Semaphorin-3A 86%
3. Genetic Therapy 78%
4. Pyramidal Tracts 69%
5. Trans-Activators 69%
6. Ceramides 66%
7. Viral Genes 66%
8. Neuromuscular Junction 66%
9. Amyotrophic Lateral Sclerosis 60%
10. Dopaminergic Neurons 59%
11. Transgenes 57%
12. Neurons 56%
13. Paralysis 54%
14. Spinal Cord 54%
15. Nervous System 53%
16. Amyloid 53%
17. Proteins 52%
18. Parkinson Disease 47%
19. Alzheimer Disease 43%
20. Phosphoglycerate Kinase 42%
21. Axon Guidance 41%
22. Synapsins 40%
23. caN protocol 35%
24. Substantia Nigra 34%
25. Phase II Clinical Trials 34%
26. Clinical Trials, Phase I 34%
27. Muscles 34%
28. Inflammation 33%
29. Neurobiology 33%
30. Brain 32%
31. Neurosciences 30%
32. Eye Diseases 29%
33. Alanine 28%
34. Glycine 28%
35. Brain Diseases 26%
36. Sphingomyelins 26%
37. Psychology Transfer 24%
38. Cell Culture Techniques 21%
39. EBV-encoded nuclear antigen 1 21%
40. Gene Expression 21%
41. Schwann Cells 21%
42. Cues 21%
43. Spinal Cord Regeneration 20%
44. Oligodendroglia 20%
45. Epstein-Barr Virus Nuclear Antigens 20%
46. Light 20%
47. Research Personnel 19%
48. T-Lymphocytes 17%